Echo Street Capital Management’s 10x Genomics TXG Stock Holding History

Echo Street Capital Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,429	Closed	-$471K	–	583
2023 Q2	$471K	Buy	+8,429	New	+$456K	﹤0.01%	280
2022 Q2	–	Sell	-3,406	Closed	-$259K	–	717
2022 Q1	$259K	Buy	+3,406	New	+$298K	﹤0.01%	528
2021 Q4	–	Sell	-1,771	Closed	-$258K	–	751
2021 Q3	$258K	Buy	1,771 +674	+61%	+$116K	﹤0.01%	539
2021 Q2	$215K	Buy	+1,097	New	+$199K	﹤0.01%	546

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Echo Street Capital Management's TXG Position: Q3 2023 in Review

Echo Street Capital Management sold out of 10x Genomics (TXG) in Q3 2023, closing a stake of 8,429 shares — an estimated $471K sold.

Echo Street Capital Management first reported a position in TXG in Q2 2021 and held it in 4 quarters. The position peaked at $471K in Q2 2023. 256 funds tracked by Wall St. Rank hold TXG as of Q3 2023.

Echo Street Capital Management reported no remaining 10x Genomics position as of Q3 2023 after selling out during the quarter.
Echo Street Capital Management sold 8,429 10x Genomics shares in Q3 2023, an estimated $471K.
Echo Street Capital Management first reported a position in 10x Genomics in Q2 2021 and held it in 4 quarters.
Echo Street Capital Management's 10x Genomics position peaked at $471K in Q2 2023.
256 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2023.

Based on Echo Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.